{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,15]],"date-time":"2024-09-15T17:29:09Z","timestamp":1726421349373},"reference-count":23,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2008,7,1]],"date-time":"2008-07-01T00:00:00Z","timestamp":1214870400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Lung Cancer"],"published-print":{"date-parts":[[2008,7]]},"DOI":"10.1016\/j.lungcan.2007.11.010","type":"journal-article","created":{"date-parts":[[2008,1,8]],"date-time":"2008-01-08T10:32:44Z","timestamp":1199788364000},"page":"123-128","source":"Crossref","is-referenced-by-count":5,"title":["Irinotecan and cisplatin with concurrent thoracic radiotherapy in a once-every-three-weeks schedule in patients with limited-disease small-cell lung cancer: A phase I study"],"prefix":"10.1016","volume":"61","clinical-trial-number":[{"clinical-trial-number":"isrctn75771514","registry":"10.18810\/isrctn"}],"author":[{"given":"W.K.","family":"de Jong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.J.A.","family":"de Jonge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.H.D.","family":"van der Leest","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.P.","family":"van Meerbeeck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.J.M.","family":"Groen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.lungcan.2007.11.010_bib1","doi-asserted-by":"crossref","first-page":"3054","DOI":"10.1200\/JCO.2002.12.071","article-title":"Phase III study of concurrent versus sequential thoracic radiotherapy in combination with cisplatin and etoposide for limited-stage small-cell lung cancer: results of the Japan Clinical Oncology Group Study 9104","volume":"20","author":"Takada","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.lungcan.2007.11.010_bib2","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/S0140-6736(05)67569-1","article-title":"Small-cell lung cancer","volume":"366","author":"Jackman","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.lungcan.2007.11.010_bib3","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1200\/JCO.2000.18.1.195","article-title":"Pharmacokinetic, metabolic, and pharmacodynamic profiles in a dose-escalating study of irinotecan and cisplatin","volume":"18","author":"de Jonge","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.lungcan.2007.11.010_bib4","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1056\/NEJM199908123410703","article-title":"Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. Prophylactic Cranial Irradiation Overview Collaborative Group","volume":"341","author":"Auperin","year":"1999","journal-title":"N Engl J Med."},{"key":"10.1016\/j.lungcan.2007.11.010_bib5","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1056\/NEJMoa003034","article-title":"Irinotecan plus cisplatin compared with etoposide plus cisplatin for extensive small-cell lung cancer","volume":"346","author":"Noda","year":"2002","journal-title":"N Engl J Med."},{"key":"10.1016\/j.lungcan.2007.11.010_bib6","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1200\/JCO.2005.04.8595","article-title":"Randomized phase III trial comparing irinotecan\/cisplatin with etoposide\/cisplatin in patients with previously untreated extensive-stage disease small-cell lung cancer","volume":"24","author":"Hanna","year":"2006","journal-title":"J Clin Oncol."},{"key":"10.1016\/j.lungcan.2007.11.010_bib7","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1200\/JCO.2005.03.3332","article-title":"Open-label, multicenter, randomized, phase III study comparing oral topotecan\/cisplatin versus etoposide\/cisplatin as treatment for chemotherapy-naive patients with extensive-disease small-cell lung cancer","volume":"24","author":"Eckardt","year":"2006","journal-title":"J Clin Oncol."},{"key":"10.1016\/j.lungcan.2007.11.010_bib8","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.lungcan.2006.04.012","article-title":"Simultaneous chemoradiotherapy with irinotecan and cisplatin in limited disease small cell lung cancer: a phase I study","volume":"53","author":"Klautke","year":"2006","journal-title":"Lung Cancer."},{"key":"10.1016\/j.lungcan.2007.11.010_bib9","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.lungcan.2006.06.002","article-title":"Phase II study of irinotecan plus cisplatin with concurrent radiotherapy for the patients with limited-disease small-cell lung cancer","volume":"53","author":"Jeong","year":"2006","journal-title":"Lung Cancer."},{"key":"10.1016\/j.lungcan.2007.11.010_bib10","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1016\/S0959-8049(02)00191-0","article-title":"Phase I study of irinotecan and cisplatin with concurrent split-course radiotherapy in limited-disease small-cell lung cancer","volume":"38","author":"Oka","year":"2002","journal-title":"Eur J Cancer."},{"key":"10.1016\/j.lungcan.2007.11.010_bib11","doi-asserted-by":"crossref","first-page":"3488","DOI":"10.1200\/JCO.2005.01.082","article-title":"Phase II study of irinotecan plus cisplatin induction followed by concurrent twice-daily thoracic irradiation with etoposide plus cisplatin chemotherapy for limited-disease small-cell lung cancer","volume":"23","author":"Han","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.lungcan.2007.11.010_bib12","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1002\/cncr.22621","article-title":"Phase II trial of irinotecan and cisplatin with early concurrent radiotherapy in limited-disease small-cell lung cancer","volume":"109","author":"Sohn","year":"2007","journal-title":"Cancer."},{"key":"10.1016\/j.lungcan.2007.11.010_bib13","doi-asserted-by":"crossref","first-page":"7084","DOI":"10.1200\/jco.2006.24.18_suppl.7084","article-title":"Phase II study of irinotecan and cisplatin regimen with concurrent thoracic radiotherapy in limited-stage small cell lung cancer (LS-SCLC)","volume":"24","author":"Castellano","year":"2006","journal-title":"Proc Am Soc Clin Oncol."},{"key":"10.1016\/j.lungcan.2007.11.010_bib14","doi-asserted-by":"crossref","first-page":"7058","DOI":"10.1200\/jco.2006.24.18_suppl.7058","article-title":"Phase I study of irinotecan and cisplatin in combination with thoracic radiotherapy, either twice daily (45Gy) or once daily (70Gy), in patients with limited small cell lung cancer: Early analysis of RTOG0241","volume":"24","author":"Langer","year":"2006","journal-title":"Proc Am Soc Clin Oncol."},{"key":"10.1016\/j.lungcan.2007.11.010_bib15","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1016\/S0140-6736(03)13780-4","article-title":"The camptothecins","volume":"361","author":"Pizzolato","year":"2003","journal-title":"Lancet."},{"key":"10.1016\/j.lungcan.2007.11.010_bib16","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1200\/JCO.2000.18.1.187","article-title":"Phase I study of 3-week schedule of irinotecan combined with cisplatin in patients with advanced solid tumors","volume":"18","author":"de Jonge","year":"2000","journal-title":"J Clin Oncol."},{"key":"10.1016\/j.lungcan.2007.11.010_bib17","first-page":"1136","article-title":"Modulation of irinotecan-induced diarrhea by cotreatment with neomycin in cancer patients","volume":"7","author":"Kehrer","year":"2001","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.lungcan.2007.11.010_bib18","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1056\/NEJM199901283400403","article-title":"Twice-daily compared with once-daily thoracic radiotherapy in limited small-cell lung cancer treated concurrently with cisplatin and etoposide","volume":"340","author":"Turrisi","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lungcan.2007.11.010_bib19","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1200\/JCO.20.1.81","article-title":"Impact of body-size measures on irinotecan clearance: alternative dosing recommendations","volume":"20","author":"Mathijssen","year":"2002","journal-title":"J Clin Oncol."},{"key":"10.1016\/j.lungcan.2007.11.010_bib20","doi-asserted-by":"crossref","first-page":"3733","DOI":"10.1200\/JCO.2001.19.17.3733","article-title":"Body-surface area-based dosing does not increase accuracy of predicting cisplatin exposure","volume":"19","author":"de Jongh","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.lungcan.2007.11.010_bib21","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1200\/JCO.2005.03.0239","article-title":"Comprehensive analysis of UGT1A polymorphisms predictive for pharmacokinetics and treatment outcome in patients with non-small-cell lung cancer treated with irinotecan and cisplatin","volume":"24","author":"Han","year":"2006","journal-title":"J Clin Oncol."},{"key":"10.1016\/j.lungcan.2007.11.010_bib22","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1634\/theoncologist.11-8-944","article-title":"Prophylaxis of irinotecan-induced diarrhea with neomycin and potential role for UGT1A1*28 genotype screening: a double-blind, randomized, placebo-controlled study","volume":"11","author":"de Jong","year":"2006","journal-title":"Oncologist."},{"key":"10.1016\/j.lungcan.2007.11.010_bib23","doi-asserted-by":"crossref","first-page":"7523","DOI":"10.1200\/jco.2007.25.18_suppl.7523","article-title":"A randomized phase III trial of irinotecan plus carboplatin versus etoposide plus carboplatin in patients with small cell lung cancer, extensive disease (SCLC-ED): IRIS-Study","volume":"25","author":"Hermes","year":"2007","journal-title":"Proc Am Soc Clin Oncol."}],"container-title":["Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500207006745?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500207006745?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,30]],"date-time":"2020-04-30T10:05:51Z","timestamp":1588241151000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169500207006745"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,7]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,7]]}},"alternative-id":["S0169500207006745"],"URL":"https:\/\/doi.org\/10.1016\/j.lungcan.2007.11.010","relation":{},"ISSN":["0169-5002"],"issn-type":[{"type":"print","value":"0169-5002"}],"subject":[],"published":{"date-parts":[[2008,7]]}}}